SEC Form 4 · accession 0001209191-19-009987
TEVA PHARMACEUTICAL INDUSTRIES LTD · TEVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Sabag
Officer — EVP, Global Human Resources
Period of report
Feb 12, 2019
Accepted (ET)
Feb 14, 2019 · 7:36 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818686
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Feb 12, 2019 | A | 9,381 | — | A | 50,898 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- F2The Ordinary Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units.